Middle East News Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.

Press releases published on March 25, 2026

Mar. 25, 2026

ControlMonkey Extends Cloud Configuration Disaster Recovery to Observability Platforms

Indeterminate GlobeNewswire

Mar. 25, 2026

Tower Semiconductor and Nuvoton Technology Corporation Japan Announce Strategic Business Restructuring of TPSCo

Indeterminate GlobeNewswire

Mar. 25, 2026

Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

Indeterminate GlobeNewswire

Mar. 25, 2026

Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome

Indeterminate GlobeNewswire

Mar. 25, 2026

GoldHaven Closes $1.72 Million First Tranche Flow-Through Financing to Fund 2026 Drill Program Targeting High-Grade at Magno Project

Indeterminate GlobeNewswire

Mar. 25, 2026

Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48

Indeterminate GlobeNewswire

Mar. 25, 2026

ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026

Indeterminate GlobeNewswire

Mar. 25, 2026

Skyharbour Announces Appointment of Rob Chang to Board of Directors and Amanda Chow as Chief Financial Officer

Indeterminate GlobeNewswire

Mar. 25, 2026

ORYZON Strengthens Vafidemstat Patent Portfolio With U.S. Notice of Allowance

Indeterminate GlobeNewswire

Mar. 25, 2026

Avalyn Announces Publication Demonstrating Correlation Between Imaging, Improved Lung Function, and Quality of Life with AP01 in Patients with Idiopathic Pulmonary Fibrosis

Indeterminate GlobeNewswire

Mar. 25, 2026

AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program

Indeterminate GlobeNewswire

Mar. 25, 2026

Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform

Indeterminate GlobeNewswire

Mar. 25, 2026

Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

Indeterminate GlobeNewswire

Mar. 25, 2026

Fredonia Mining Inc. Engages ICP Securities Inc. for Automated Market Making Services and Enters Into Investor Relations and Capital Markets Advisory Agreement

Indeterminate GlobeNewswire

Mar. 25, 2026

Bessor Announces Termination of Jagrite Graphite Project

Indeterminate GlobeNewswire

Mar. 25, 2026

Verano to Report First Quarter 2026 Financial Results on April 30, 2026

Indeterminate GlobeNewswire

Mar. 25, 2026

Koryx Copper Announces Updated Mineral Resource Estimate for the Haib Copper Project, Southern Namibia

Indeterminate GlobeNewswire

Mar. 25, 2026

NexGold Initiates 30,000-Metre Infill Drill Program at the Goldboro Gold Project in Nova Scotia

Indeterminate GlobeNewswire

Mar. 25, 2026

Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)

Indeterminate GlobeNewswire

Mar. 25, 2026

Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease

Indeterminate GlobeNewswire